Live, virtual CME training through WebEx

Join to learn about screening, diagnosing, and treating OUD, including harm reduction tools. 

Co-Hosted by: Maryland Addiction Consultation Service (MACS) and Maryland Behavioral Health Integration in Pediatric Primary Care (BHIPP)

Audience: Primary Care Physicians, Advance Practice Registered Nurses, Physician Assistants, other members of the healthcare team

Learning Objectives:

1. Review the integration of SUD treatment and primary care
2. Review the Medications for Opioid Use Disorder, including features, initiations, maintenance, and safety
3. Describe the process of buprenorphine initiation as well as stabilization and maintenance
4. Describe how to take a patient history and evaluation
5. Discuss the importance of harm reduction

Presenter:

Mike Fingerhood, MD
Consultant, Maryland Addiction Consultation Service (MACS)
Associate Professor of medicine and public health, Johns Hopkins University

Disclosure Information: 
The planners and reviewers for this activity have reported no relevant financial relationships to disclose. 


Event contact: Bridget Sweeney, MACS Training Coordinator MACSTraining@som.umaryland.edu

CME Credit:
“This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedChi, The Maryland State Medical Society and the Maryland Health Care Commission (MHCC). MedChi is accredited by the ACCME to provide continuing medical education for physicians. MedChi designates this virtual online educational activity for a maximum of 1 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.” 

CEU Credit:
Maryland Addiction Consultation Service (MACS) of the University of Maryland School of Medicine, Department of Psychiatry is authorized as a sponsor of Continuing Education Units. MACS maintains responsibility for this program.

MAT and MATE Acts: 

This training counts toward the 8-hour SUD training requirement to renew or get your DEA license. 

On December 29, 2022, President Biden signed the fiscal year 2023 omnibus, passing the Mainstreaming Addiction Treatment (MAT) and Medication Access and Training Expansion (MATE) Acts. These bills were passed to expand access to buprenorphine for the treatment of opioid use disorder, and normalize and enhance substance use care across healthcare settings.

MACS is monitoring guidance from state and federal agencies closely and will update this page when more information becomes available. The resources on this page offer information about the omnibus, the bills, and the implications for healthcare providers and programs. Find out more here: https://www.marylandmacs.org/MAT--MATE-Acts/